D.MacKay and F.Fitz, “Geographic Location and Moral Arbitrariness in the Allocation of Donated Livers,”Journal of Law, Medicine & Ethics, 47, no. 2 (2019): 308-319.
3.
Organ Procurement and Transplantation Network, 42 C.F.R. § 121.8 (2011).
4.
Council on Ethical and Judicial Affairs, American Medical Association, “Opinion 11.1.3, Allocating Limited Health Care Resources,” in Code of Medical Ethics (Chicago: American Medical Association, 2017): at 185.
5.
K.Ross, R.E.Patzer, D.S.Goldberg, and R.J.Lynch, “Sociodemographic Determinants of Waitlist and Posttransplant Survival Among End-Stage Liver Disease Patients,”American Journal of Transplantation17, no. 11 (2017): at 2879-2889.
6.
W.C.Chapman, “The new lottery ticket: Share 35,”Liver Transplantation22, no. 4 (2016): 393-395.
Committee on Organ Procurement and Transplantation Policy, Institute of Medicine, Organ Procurement and Transplantation: Assessing Current Policies and the Potential Impact of the DHHS Final Rule (Washington D.C., National Academies Press,1999): at 6.